Nanomol Technologies is both a drug delivery and a contract analysis partner for pharmaceutical and biotech industries.
Our DELOS nanoformulation platform enables the development of high added-value medicines with enhanced efficacy, selectivity and reduced side-effects.
We provide value to companies who require appropriate characterization of critical quality attributes such as particle size, morphology and structural properties of both drug substance and drug products.